Manufacturer: AVoGen Lab
Pharmaceutical name: Yohimbine, Clenbuterol Hydrochloride
Pack: 1 vial (10 ml (5.6 mg/30 mcg/ml))
HELIOS-Gen contains the following per ml:
Yohimbine - 5.6 mg
Clenbuterol - 30 mcg
HELIOS-Gen is formulated with Clenbuterol Hydrochloride and Yohimbine Hydrochloride, creating a highly effective mix of a beta and alpha antagonist. Both Clenbuterol and Yohimbine facilitate fat loss via the adrenergic system, but they operate through distinct mechanisms.
Clenbuterol is recognized as a thermogenic agent that directly activates fat cells and speeds up the conversion of triglycerides into free fatty acids.
Yohimbine works as an alpha-2 receptor antagonist, which can alter sympathetic activity to noticeably boost lipolysis.
It also possesses a natural ability to enhance norepinephrine release at synapses, a key hormone involved in lipolysis. Thus, it effectively combines both beta-stimulating and alpha-blocking effects, making it a perfect choice for promoting fat loss.
Users of this product provide clear evidence that localized fat loss is indeed achievable, even in stubborn areas where fat is difficult to eliminate. For those skeptical that all injectables ultimately enter circulation and cannot remain effective in a specific area, HELIOS-Gen demonstrates that targeted fat reduction is feasible.